If I were the ADXS Board and large institutional investors, I would give O'Connor an ultimatum to get ADXS' valuation up to parity with ADRO by the end of 2017 (or else Danny steps down). Considering that ADXS arguably has a stronger platform and more trials at work and more advanced than ADRO (we have a Phase 3 in play) there is no reason we should be at a $330 million valuation while ADRO is at a $760 million valuation. The difference boils down to leadership and business execution, which ADRO has shown it has the edge on. Let's see what you got Dan. At the end of 2017, Dan will have been CEO of ADXS for four and a half years. To date, he has not generated a return/value on the capital he has raised yet ($200 million raised at a weighted average price of $12 compared to the current sub-$9 price). Four and a half years is plenty of time for Dan to execute a business plan that adds shareholder value. Honestly, I wish him the best and hope he succeeds, because we all win if he gets our stock price and valuation up. If not, I don't think it will do the company any good if he's able to stick around beyond 2017.
News 
Market Data 
Discover 
